APA استشهاد

Wu, Y. L., Fukuoka, M., Mok, T. S., Saijo, N., Thongprasert, S., Yang, J. C., . . . Rukazenkov, Y. (2018). Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study.

استشهاد بنمط شيكاغو

Wu, Yi Long, Masahiro Fukuoka, Tony S.K Mok, Nagahiro Saijo, Sumitra Thongprasert, James C.H Yang, Da Tong Chu, Jin Ji Yang, و Yuri Rukazenkov. Tumor Response and Health-related Quality of Life in Clinically Selected Patients From Asia With Advanced Non-small-cell Lung Cancer Treated With First-line Gefitinib: Post Hoc Analyses From the IPASS Study. 2018.

MLA استشهاد

Wu, Yi Long, et al. Tumor Response and Health-related Quality of Life in Clinically Selected Patients From Asia With Advanced Non-small-cell Lung Cancer Treated With First-line Gefitinib: Post Hoc Analyses From the IPASS Study. 2018.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.